Similar articles

• High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism.

  Biscetti F, Straface G, De Cristofaro R, Lancellotti S, Rizzo P, Arena V, Stigliano E, Pecorini G, Egashira K, De Angelis G, Ghirlanda G, Flex A. Biscetti F, et al. Diabetes. 2010 Jun;59(6):1496-505. doi: 10.2337/db09-1507. Epub 2010 Mar 3. Diabetes. 2010. PMID: 20200317 Free PMC article.
• In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.

  Li Y, Hazarika S, Xie D, Pippen AM, Kontos CD, Annex BH. Li Y, et al. Diabetes. 2007 Mar;56(3):656-65. doi: 10.2337/db06-0999. Diabetes. 2007. PMID: 17327433
• Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.

  Hazarika S, Dokun AO, Li Y, Popel AS, Kontos CD, Annex BH. Hazarika S, et al. Circ Res. 2007 Oct 26;101(9):948-56. doi: 10.1161/CIRCRESAHA.107.160630. Epub 2007 Sep 6. Circ Res. 2007. PMID: 17823371
• Vascular endothelial growth factor and the regulation of angiogenesis.

  Ferrara N. Ferrara N. Recent Prog Horm Res. 2000;55:15-35; discussion 35-6. Recent Prog Horm Res. 2000. PMID: 11036931 Review.
• Therapeutic potential of high mobility group box-1 in ischemic injury and tissue regeneration.

  Biscetti F, Ghirlanda G, Flex A. Biscetti F, et al. Curr Vasc Pharmacol. 2011 Nov;9(6):677-81. doi: 10.2174/157016111797484125. Curr Vasc Pharmacol. 2011. PMID: 21692740 Review.